ArticleBMC cancer2016

Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study.

Pashtoon M Kasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.